Professional Documents
Culture Documents
Generic Name: As stated, carvedilol is > indicated for >contraindicated in >Body as a >Do not engage in hazardous
Carvedidol a non-selective the chronic therapy of patients with Whole: Increased activities while experiencing
adrenergic blocker, heart failure with bronchial asthma or sweating, fatigue, dizziness.
Brand Name: and more reduced ejection related chest pain, pain,
Coreg, Coreg CR specifically, is a non- fraction (HFrEF), bronchospastic arthralgia.
selective beta-blocker hypertension, and left conditions, >Do not abruptly discontinue
Classification: with alpha1-adrenergic ventricular decompensated >CV: Bradycardia, taking this drug.
Beta-blockers receptor antagonist dysfunction following NYHA functional hypotension, syncope,
properties. It is a non- myocardial infarction class IV heart failure hypertension, AV
selective, cardiac beta- (MI) in clinically stable requiring block, angina.
blocker with peripheral patients intravenous >Monitor for worsening of
vasodilating effects. inotropic therapy, >GI: Diarrhea, nausea, symptoms
Secondary to its unique severe liver abdominal pain,
action, carvedilol impairment, second- vomiting
maintains cardiac or third-degree
output by decreasing atrioventricular
afterload in block, sick sinus
conjunction with a syndrome (unless a
cardiac beta-blockade permanent
and has a lesser effect pacemaker is in
on heart rate than pure place), cardiogenic
selective beta-blockers. shock, severe
Other benefits include bradycardia or
antioxidant effects, known
reduction in neutrophil hypersensitivity to
infiltration, apoptosis the drug.
inhibition, reduction of
vascular smooth
muscle migration, and
improvement of
myocardial remodeling
post-acute myocardial
infarction. Because
carvedilol can prevent
the formation of
oxidized low-
density lipoproteins
and inhibit vascular
smooth muscle cell
proliferation and
migration, it shows a
great promise in
treating atherosclerotic
disease formation and
progression.
Name of Drugs Mechanism of Indications Contraindications Adverse Effect Nursing
Action Responsibilities
Generic Name: Terazosin dilates Mild to Moderate >Hypersensitivity >Monitor dizziness, >Monitor blood
Terazosin hcl both arteries and hypertension headache, pressure (lying and
veins by blocking (alone or with weakness, standing) and pule
Brand Name: postsynaptic alpha- other agents.) drowsiness, frequently during
Hytrin adrenergic Urinary outflow nervousness, and initial dose
receptors. obstruction in dyspnea. adjustment and
Classification: Decreases patients with periodically during
Alpha Blockers, contractions in prostatic therapy.
Antihypertensives smooth muscle of hyperplasia.
the prostatic >Assess patient for
capsule. >First dose first-dose
orthostatic orthostatic
hypotension, hypotension and
arrhythmias, chest syncope. May occur
pain, palpitation, 30 mins-2 hrs after
peripheral edema, initial dose and
tachycardia. occasionally
thereafter.
Incidence may be
dose related.
Volume-depleted
or sodium-
restricted patients
may be more
>Nausea vomiting sensitive to this
abdominal pain effect.
diarrhea, dry
mouth. >Monitor intake
and output ratios
and daily weight,
assess for edema
daily, especially at
beginning of
therapy.